Associate Director, Commercial Insights and Analytics, Early Pipeline

Arvinas is a clinical-stage biotechnology company dedicated to improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development, and commercialization of therapies that degrade disease-causing proteins. Arvinas uses its proprietary PROTAC® Discovery Engine platform to engineer proteolysis targeting chimeras, or PROTAC® targeted protein degraders, that are designed to harness the body’s own natural protein disposal system to selectively and efficiently degrade and remove disease-causing proteins.

In addition to its robust preclinical pipeline of PROTAC protein degraders against validated and “undruggable” targets, the company has three investigational clinical-stage programs currently enrolling: vepdegestrant for the treatment of patients with locally advanced or metastatic ER+/HER2- breast cancer; ARV-102 for the treatment of patients with neurodegenerative disorders, and ARV-393 for the treatment of patients with relapsed/refractory non-Hodgkin Lymphoma and potentially other lymphomas.

In April 2024, Arvinas entered into a transaction with Novartis, including a global license agreement for the development and commercialization of the clinical stage PROTAC® androgen receptor protein degrader ARV-766 for the treatment of prostate cancer. The transaction closed in May 2024.

#TeamArvinas is made up of approximately 450 passionate and curious employees, whose diverse thoughts and perspectives are highly valued. Arvinas employees embrace the freedom to pursue innovation, think creatively, and give back. They are driven by the company’s values and mission – to improve the lives of patients with serious diseases by pioneering therapies created with our revolutionary PROTAC® protein degradation platform. We’re really excited about the work we’re doing inside and outside of Arvinas, and think you will be, too. But don’t just take our word for it – learn more about life at Arvinas and what employees have to say.

For more information, please visit www.arvinas.com. 

 

Position Summary

The Associate Director, Commercial Insights and Analytics, Early Pipeline. This role will be responsible for providing strategic commercial and competitive intelligence insights for preclinical and clinical programs, and new target assessments to support Arvinas’ portfolio. This includes developing a strong viewpoint on evolving treatment landscape and unmet needs, and competitive landscape for Arvinas’ preclinical and clinical programs.  This role will work closely cross-functionally to answer strategic questions to advance Arvinas’ portfolio. This role offers an opportunity to help shape the strategy to deliver a new transformative drug modality to patients with high unmet needs.

This position reports to the Executive Director, Commercial Insights and Analytics, and can be located at our headquarters in New Haven, CT or work remotely from a location within the U.S.

 

Principal Responsibilities

Key responsibilities of this role include, but are not limited to:

• Conduct commercial assessments of potential therapeutic targets and preclinical programs
• Develop and communicate strong understanding of treatment protocols, unmet needs, potential patient segments, and competitive pipeline to identify optimal target product profiles
• Crystalize commercial and strategic insights by synthesizing product, brand, customer, and competitive information to inform strategic asset development
• Develop target product profiles for early-stage R&D programs, based on thorough understanding of market dynamics and potential future trends
• Map and assess competitive dynamics in key indications and/or therapeutic areas
• Undertake research on complex questions, gather and analyze data and turn these data into a succinct response and/or recommendation that can be used directly by the leadership
• Translate key insights from scientific experts (internally